Drug · DIN 02401495
AMOXICILLIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 4, 2018; first marketed February 14, 2013.
- Drug Identification Number (DIN)
- 02401495
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Amoxicillin J01CA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMOXICILLIN (AMOXICILLIN TRIHYDRATE) | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 13, 2013: NOC 14089New Drug Submission (NDS) · New manufacturer and product name
Other DINs named AMOXICILLIN
- DIN 02352753 · Marketed
- DIN 02352788 · Marketed
- DIN 02401509 · Marketed
- DIN 02401541 · Marketed
- DIN 02237154 · Cancelled Pre Market
- DIN 02352710 · Dormant
- DIN 02352729 · Dormant
- DIN 02352737 · Cancelled Post Market
- DIN 02352745 · Cancelled Post Market
- DIN 02352761 · Cancelled Post Market
- DIN 02434709 · Cancelled Pre Market
- DIN 02434717 · Cancelled Pre Market